Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
Eli Lilly(LLY) stock is priced at $1,184.51, giving the company a market capitalization of 1.12T. It carries a P/E multiple of 40.25 and pays a dividend yield of 0.56%.
On 2026-09-30, Eli Lilly(LLY) stock traded between a low of $1,175.77 and a high of $1,214.99. Shares are currently priced at $1,184.51, which is +0.7% above the low and -2.5% below the high.
The Eli Lilly(LLY)'s current trading volume is 764.65K, compared to an average daily volume of 2.3M.
During the past year, Eli Lilly(LLY) stock moved between $725.31 at its lowest and $1,292.65 at its peak.
During the past year, Eli Lilly(LLY) stock moved between $725.31 at its lowest and $1,292.65 at its peak.
LLY News
In the race to come up with newer and better weight-loss drugs, Eli Lilly appears to have found a powerful combination. The pairing of a promising new drug wit...
Eli Lilly (LLY) announced “positive” results from a Phase 2b trial evaluating the safety and efficacy of EloraTZP. Eloralintide alone reduced body weight by up...
...
Analyst ratings
84%
of 32 ratingsMore LLY News
Lilly signage during a groundbreaking ceremony for Eli Lilly and Company's pharmaceutical manufacturing campus at Generation Park in Houston, Texas, US, on Mond...
An Eli Lilly office in San Diego. Mike Blake / Reuters A next-generation weight-loss drug from Eli Lilly LLY 2.04 %increase; up pointing triangle , when combin...
Evan Seigerman, an analyst from BMO Capital, maintained the Buy rating on Eli Lilly & Co. The associated price target remains the same with $1,400.00. Evan Sei...
These 7 Stocks Are Analyst Favorites For Magnificent Earnings Growth; Amazon In New Base 9/30/2026 Among the best stocks in earnings performance, highly rated...
Eli Lilly (LLY) announced on Wednesday that Ebglyss, an antibody therapy it markets with Spanish pharma company Almirall (LBTSF) (ALMRY), succeeded in a Phase 3...
(RTTNews) - Eli Lilly (LLY) said EBGLYSS (lebrikizumab-lbkz) met the primary and secondary endpoints in the Phase 3b ADtouch study, showing significant improvem...
Eli Lilly (LLY) and Company announced that ebglyss monotherapy met its primary and secondary endpoints at Week 16 in the Phase 3b ADtouch study, showing signifi...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.